The management of mood disorders in pregnancy: alternatives to antidepressants

  title={The management of mood disorders in pregnancy: alternatives to antidepressants},
  author={Erica M. Richards and Jennifer L. Payne},
  journal={CNS Spectrums},
  pages={261 - 271}
The management of mood disorders during pregnancy is complex due to risks associated with medication use and risks associated with untreated depression. Antidepressant use during pregnancy is an exposure for the unborn child, and it currently remains unclear what long-term repercussions there might be from this exposure, though available data are reassuring. On the other hand, there are risks for both the mother and child of untreated depression during pregnancy. There is a real need for… 

Use of Psychotropic Medication during Pregnancy and the Postpartum Period

A review of selected studies will highlight some of the current issues with the use of psychotropic medications during pregnancy and the postpartum period.

Bipolar Depression: Pregnancy, Postpartum, and Lactation.

Neuromodulation of chronic headaches: position statement from the European Headache Federation

Any neurostimulation device should only be used in patients with medically intractable syndromes from tertiary headache centers either as part of a valid study or have shown to be effective in such controlled studies with an acceptable side effect profile.

Use of electroconvulsive therapy in the Baltic states

This 2010 survey revealed significant differences in the use and availability of ECT between the Baltic countries.

Electroconvulsive Therapy Practice in Ukraine

The provision of ECT in only 8 centers is clearly insufficient for a large country such as Ukraine, which is reflected in the low rate of inpatients treated with ECT, which should be addressed by the Ukrainian health authorities.

Is Conduct of Research in Electroconvulsive Therapy Ethical?

  • N. YoussefW. McCall
  • Psychology
    Journal of psychology, neuropsychiatric disorders and brain stimulation
  • 2016
ECT research is ethical; and more research in this field could help decrease stigma and barriers to treatment, and/or reduce side effects and improve efficacy of a potentially life-saving intervention.

Phototherapy during pregnancy and lactation

The objective of this work is to review the risks of phototherapy (including nb-uvb, excimer laser, visible light, uva-1) photochemotherapy, and photodynamic therapy during pregnancy



Pharmacological Aspects of Neonatal Antidepressant Withdrawal

The reader should be able to explain the importance of antidepressant therapy during pregnancy and postpartum, summarize the important neonatal effects of antidepressants, and describe the potential teratogenic effects ofidepressants.

Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment.

Pregnancy is not "protective" with respect to risk of relapse of major depression, and women with histories of depression who are euthymic in the context of ongoing antidepressant therapy should be aware of the association of depressive relapse during pregnancy with antidepressant discontinuation.

Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression.

  • C. DennisK. Allen
  • Medicine, Psychology
    The Cochrane database of systematic reviews
  • 2008
The evidence is inconclusive to allow us to make any recommendations for massage therapy or depression-specific acupuncture for the treatment of antenatal depression, and one US three-armed randomised controlled trial was too small with a non-generalisable sample.

Psychosocial and psychological interventions for treating antenatal depression.

Interpersonal psychotherapy compared to a parenting education program was associated with a reduction in the risk of depressive symptomatology immediately post-treatment, and the evidence is inconclusive to allow for recommendations for interpersonal psychotherapy for the treatment of antenatal depression.

Antidepressant Use During Pregnancy: Current Controversies and Treatment Strategies

The safety of antidepressant use during pregnancy seems to be largely reassuring but there remain 2 areas of controversy including neonatal withdrawal syndrome and primary pulmonary hypertension of the newborn.

A Review of Continuation and Maintenance Electroconvulsive Therapy

  • K. RabheruE. Persad
  • Medicine, Psychology
    Canadian journal of psychiatry. Revue canadienne de psychiatrie
  • 1997
Continuation and maintenance C/MECT has been found to be efficacious, safe, well tolerated, and cost-effective in reducing relapse, recurrence, and rehospitalization, particularly in the management of recurrent mood disorders in the elderly.

The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists.

Antidepressant use in pregnancy is well studied, but available research has not yet adequately controlled for other factors that may influence birth outcomes including maternal illness or problematic health behaviors that can adversely affect pregnancy.

Nonpharmacologic intervention and prevention strategies for depression during pregnancy and the postpartum.

The evidence base suggests that efficacious nonpharmacologic options are available for women during pregnancy and postpartum; however, important research questions remain.

Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.

While transient neonatal symptoms were found in infants after single-agent prenatal exposure to SSRIs, the addition of clonazepam appeared to alter paroxetine metabolism, leading to increased drug levels and risk for transient Neonatal symptoms.